Everything tagged "atto" across the TickerSpark archives.
Attovia Therapeutics, Inc. (NASDAQ: ATTO) is expected to list on 2026-08-05, but the price range has not been disclosed. The company plans to offer 17,000,000 shares. The setup is attractive if investors want early-stage immunology exposure, but the story still depends on clinical execution and funding discipline.
Atento S.A. is expected to list on NASDAQ on 2026-08-05 in a 12,500,000-share offering priced at $15.00 to $17.00 per share. The implied market cap is $244,375,000 if priced at the midpoint. The bull case is a scaled CRM/BPO platform with AI and nearshore delivery; the bear case is that the company already appears to be a long-established public issuer, so investors should watch closely for confirmation of what is actually being offered.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime